Onyx Pharmaceuticals Announces Second Quarter 2008 Financial Results Teleconference and Webcast
30 July 2008 - 10:00PM
PR Newswire (US)
EMERYVILLE, Calif., July 30 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
webcast a teleconference with management to discuss second quarter
2008 financial results and provide a general business overview on
Tuesday, August 5, 2008, at 5:00 p.m. Eastern Time (2:00 p.m.
Pacific Time). Financial results for the second quarter ended June
30, 2008 will be released earlier that day. Interested parties may
access a live webcast of the presentation on our website at:
http://www.onyx-pharm.com/wt/page/event_calendar or by dialing
847-413-3235 and using the passcode 22274059. A replay of the
presentation will be available on the Onyx website or by dialing
630-652-3044 and using the passcode 22274059 approximately one hour
after the teleconference concludes. The replay will be available
through September 4, 2008. Onyx Pharmaceuticals, Inc. is a
biopharmaceutical company committed to improving the lives of
people with cancer by changing the way cancer is treated(TM). The
company, in collaboration with Bayer HealthCare Pharmaceuticals,
Inc., is developing and marketing Nexavar(R), a small molecule
drug. Nexavar is currently approved for the treatment of liver
cancer and advanced kidney cancer. Additionally, Nexavar is being
investigated in several ongoing trials in non-small cell lung
cancer, melanoma, breast cancer, and other cancers. For more
information about Onyx, visit the company's website at
http://www.onyx-pharm.com/. Nexavar(R) (sorafenib) tablets is a
registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alex Santos of Onyx
Pharmaceuticals, Inc., +1-510-597-6504 Web site:
http://www.onyx-pharm.com/
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals (MM) News Articles